Skip to content
Search

Latest Stories

Covid-19 has created an 'ecosystem' of innovation in India: Biocon chief Kiran Mazumdar-Shaw

Covid-19 has created an 'ecosystem' of innovation in India: Biocon chief Kiran Mazumdar-Shaw

EVERY crisis creates an opportunity and the coronavirus pandemic has been no different. Biocon chief Kiran Mazumdar-Shaw feels the same as she said ahead of the annual India-

US bio-pharma summit in Boston next week that the ongoing health crisis has led to the creation of an “ecosystem” of innovation in India.


The 68-year-old Mazumdar-Shaw is one of the key speakers at the 15th edition of the annual virtual summit which will be hosted by the USA India Chamber of Commerce on June 22. Among other high-profile speakers of the event are Dr Albert Bourla, Chairman and CEO of Pfizer; Dr Francis Collins, Director, National Institutes of Health; Dr Janet Woodcock, Acting Commissioner, US Food and Drug Administration; and Amitabh Kant, CEO of India’s NITI Aayog.

GettyImages 1233350621 A health worker inoculate man with a dose of the Covaxin vaccine against the Covid-19 coronavirus at the KC General Hospital, in Bangalore on June 9, 2021. (Photo by MANJUNATH KIRAN/AFP via Getty Images)

“The whole intent (of the more than a decade old annual India-US bio pharma summit) is to catalyse an innovation ecosystem in India. I think, COVID has actually created the ecosystem,” Mazumdar-Shaw said in an interview with PTI.

According to her, Covid has resulted in production of innovative vaccines like Covaxin, Genova mRNA programme, and many others that the Indian vaccine-manufacturers have licenses and developed.

“Then, of course, the whole clinical research ecosystem has been created because we’ve had so many clinical trials in India, whether it is for new repurpose drugs or vaccines...basically bridging trials, a lot of clinical trials have also happened in India,” the executive chairperson and founder of Biocon, a biotechnology company based in Bangalore, India, noting that clinical trials were once banned in India.

“And then when the whole environment opened up for clinical trials, there were not enough trials going on. Now suddenly, a whole bunch of clinical trials have gone on. A lot of clinical sites have opened. A lot of investigator-initiated studies have started,” the billionaire entrepreneur said, adding: “I think the whole understanding that you’ve just got to get into clinical trials and clinical research, to actually address a large number of unmet needs is now beginning to dawn on the Indian innovation system.”

Mazumdar-Shaw also said that India has a large number of incubators in which some very innovative programmes were being developed. “There is VC funding now getting into those programmes. So slowly, that ecosystem has been created,” she said, adding that companies from India have started operations in the US to raise funding and are also becoming a part of the American innovation ecosystem.

She said the Covid-19 crisis has also brought the pharma firms from India and the US together. Giving examples, she said Novavax has partnered with Serum Institute while the Baylor Institute has joined hands with Biological-E, etc. There are many other programmes that have been licenses from America’s academic centres, Mazumdar-Shaw added.

More For You

 electricity-pylons-iStock

From 2026, households within 500 metres of new or upgraded electricity infrastructure will receive bill reductions of up to £2,500 over 10 years. (Representational image: iStock)

Residents near new electricity pylons to get bill reductions

THE GOVERNMENT announced on Monday that households living near new electricity pylons will receive discounts on their energy bills.

The move is part of efforts to expand electricity infrastructure, despite opposition to large-scale projects needed to connect renewable energy to the grid.

Keep ReadingShow less
Donald Trump

Speaking from the Oval Office on Friday, Trump had said the US has been economically and financially 'ripped off' by several countries, including India. (Photo: Getty Images)

India denies pledge to lower tariffs following Trump’s statement

INDIA has said it has not committed to reducing import duties on US goods, following US president Donald Trump’s claim that New Delhi had agreed to "cut their tariffs way down."

Trump, in the early weeks of his second term, has taken a tough stance on global trade, imposing tariffs on several countries, including India, and accusing trading partners of unfair practices.

Keep ReadingShow less
most polluted cities

India, home to six of the world’s 10 most polluted cities, saw a 7% reduction in air pollution between 2023 and 2024

iStock

Only 7 countries meet WHO air quality guidelines, UK falls short


Air pollution is a silent killer, claiming millions of lives annually and leaving nearly every corner of the globe gasping for clean air. According to the latest annual report by Swiss air quality technology company IQAir, only seven countries worldwide met the World Health Organization’s (WHO) guidelines for safe levels of PM2.5 pollution in 2024. These countries- Australia, New Zealand, Estonia, Iceland, and a handful of small island states- stand as rare exceptions in a world where dirty air has become the norm.

Keep ReadingShow less
London-ULEZ-iStock

Signs indicating Ultra Low Emission Zone (ULEZ) on a street in London. (Photo: iStock)

London ULEZ expansion cuts pollution, increases compliance

LONDON’s air quality has improved following the expansion of the Ultra Low Emission Zone (ULEZ) across all 33 boroughs in August 2023.

The ULEZ requires vehicles that do not meet specific emission standards to pay a daily charge of £12.50. The scheme aims to tackle air pollution, climate change, and congestion.

Keep ReadingShow less
NHS England to Restructure: Workforce to Be Reduced by 50%

The changes aim to cut costs and eliminate duplication with the Department of Health and Social Care (DHSC). (Representational image: Getty)

Getty Images

NHS England to cut workforce by half in major restructuring

NHS ENGLAND will reduce its workforce from 13,000 to about 6,500 as part of a restructuring led by Health Secretary Wes Streeting.

The changes aim to cut costs and eliminate duplication with the Department of Health and Social Care (DHSC), The Guardian reported.

Keep ReadingShow less